| glycolytic process | GO:0006096 | 20 | 0.999 | Mouse |
| ribonucleoside monophosphate biosynthetic process | GO:0009156 | 9 | 0.999 | |
| hexose catabolic process | GO:0019320 | 3 | 0.997 | |
| pyruvate metabolic process | GO:0006090 | 28 | 0.995 | Mouse |
| myosin filament organization | GO:0031033 | 3 | 0.992 | |
| generation of precursor metabolites and energy | GO:0006091 | 103 | 0.984 | Mouse |
| carbohydrate catabolic process | GO:0016052 | 32 | 0.973 | Mouse |
| atp metabolic process | GO:0046034 | 75 | 0.925 | |
| ribose phosphate biosynthetic process | GO:0046390 | 59 | 0.911 | |
| purine nucleoside biosynthetic process | GO:0042451 | 19 | 0.909 | |
| purine nucleoside monophosphate biosynthetic process | GO:0009127 | 9 | 0.893 | |
| glucose catabolic process | GO:0006007 | 3 | 0.880 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.859 | |
| ribonucleoside monophosphate metabolic process | GO:0009161 | 80 | 0.859 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.846 | |
| glycosyl compound biosynthetic process | GO:1901659 | 21 | 0.841 | |
| pentose phosphate shunt | GO:0006098 | 2 | 0.834 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.794 | Mouse |
| nucleoside metabolic process | GO:0009116 | 246 | 0.778 | |
| hexose metabolic process | GO:0019318 | 98 | 0.739 | |
| nadph regeneration | GO:0006740 | 2 | 0.732 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.720 | |
| oxidation reduction process | GO:0055114 | 342 | 0.720 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.695 | |
| ribonucleoside biosynthetic process | GO:0042455 | 21 | 0.685 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.674 | |
| lactate biosynthetic process | GO:0019249 | 4 | 0.649 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.620 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.572 | |
| purine nucleoside triphosphate biosynthetic process | GO:0009145 | 7 | 0.540 | |
| ribonucleotide biosynthetic process | GO:0009260 | 59 | 0.536 | |
| glucose metabolic process | GO:0006006 | 92 | 0.528 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.527 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.521 | Mouse |
| cellular homeostasis | GO:0019725 | 240 | 0.514 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.513 | |
| nucleoside biosynthetic process | GO:0009163 | 21 | 0.509 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.506 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.506 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.499 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.495 | |
| striated muscle contraction | GO:0006941 | 45 | 0.474 | |
| purine ribonucleotide biosynthetic process | GO:0009152 | 59 | 0.465 | |
| organelle assembly | GO:0070925 | 177 | 0.433 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.424 | |
| actomyosin structure organization | GO:0031032 | 56 | 0.405 | |
| purine ribonucleoside biosynthetic process | GO:0046129 | 19 | 0.393 | |
| myofibril assembly | GO:0030239 | 34 | 0.389 | |
| muscle cell development | GO:0055001 | 133 | 0.368 | |
| myosin filament assembly | GO:0031034 | 2 | 0.363 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.343 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.320 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.308 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.304 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.299 | |
| response to decreased oxygen levels | GO:0036293 | 59 | 0.293 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.292 | |
| fructose 6 phosphate metabolic process | GO:0006002 | 1 | 0.291 | |
| sperm motility | GO:0030317 | 47 | 0.288 | Mouse |
| response to hypoxia | GO:0001666 | 58 | 0.274 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.274 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.264 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.256 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.255 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.247 | |
| energy derivation by oxidation of organic compounds | GO:0015980 | 77 | 0.246 | |
| monosaccharide metabolic process | GO:0005996 | 106 | 0.244 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.236 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.214 | |
| substantia nigra development | GO:0021762 | 2 | 0.199 | |
| glutamine family amino acid biosynthetic process | GO:0009084 | 2 | 0.196 | |
| cellular aldehyde metabolic process | GO:0006081 | 12 | 0.191 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.190 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.187 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.180 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.165 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.151 | |
| cation homeostasis | GO:0055080 | 212 | 0.151 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.147 | |
| purine ribonucleoside monophosphate biosynthetic process | GO:0009168 | 9 | 0.146 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.140 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.138 | |
| striated muscle cell development | GO:0055002 | 125 | 0.137 | |
| carbohydrate phosphorylation | GO:0046835 | 15 | 0.134 | |
| fructose metabolic process | GO:0006000 | 1 | 0.133 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.133 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.123 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.122 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.116 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.114 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.114 | |
| carbohydrate biosynthetic process | GO:0016051 | 74 | 0.113 | |
| response to heat | GO:0009408 | 27 | 0.111 | |
| glucose homeostasis | GO:0042593 | 128 | 0.109 | |
| ribonucleoside triphosphate biosynthetic process | GO:0009201 | 6 | 0.107 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.103 | |
| anion transport | GO:0006820 | 177 | 0.100 | |
| cation transport | GO:0006812 | 399 | 0.099 | |
| somitogenesis | GO:0001756 | 69 | 0.096 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.094 | |
| insulin secretion | GO:0030073 | 89 | 0.094 | |
| genitalia development | GO:0048806 | 37 | 0.092 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.089 | |
| mitotic cell cycle checkpoint | GO:0007093 | 31 | 0.085 | |
| dicarboxylic acid biosynthetic process | GO:0043650 | 5 | 0.084 | |
| pigmentation | GO:0043473 | 71 | 0.080 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.080 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.078 | |
| cellular carbohydrate catabolic process | GO:0044275 | 15 | 0.077 | |
| cofactor transport | GO:0051181 | 4 | 0.075 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.073 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.073 | |
| mesoderm formation | GO:0001707 | 62 | 0.070 | |
| oxidoreduction coenzyme metabolic process | GO:0006733 | 16 | 0.070 | |
| protein targeting | GO:0006605 | 143 | 0.070 | |
| placenta development | GO:0001890 | 140 | 0.070 | |
| regulation of coenzyme metabolic process | GO:0051196 | 4 | 0.069 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.069 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.067 | |
| regulation of cell shape | GO:0008360 | 39 | 0.065 | |
| dna integrity checkpoint | GO:0031570 | 28 | 0.064 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.064 | |
| endomembrane system organization | GO:0010256 | 147 | 0.063 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.063 | |
| midbrain development | GO:0030901 | 35 | 0.062 | |
| nucleoside triphosphate biosynthetic process | GO:0009142 | 8 | 0.062 | |
| positive regulation of insulin secretion | GO:0032024 | 26 | 0.062 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.061 | |
| oocyte axis specification | GO:0007309 | 2 | 0.060 | |
| cell adhesion | GO:0007155 | 329 | 0.059 | |
| purine ribonucleoside triphosphate biosynthetic process | GO:0009206 | 6 | 0.058 | |
| regulation of circadian sleep wake cycle | GO:0042749 | 3 | 0.057 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.056 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.056 | |
| positive regulation of hormone secretion | GO:0046887 | 38 | 0.056 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.056 | |
| aspartate family amino acid metabolic process | GO:0009066 | 10 | 0.056 | |
| transmembrane transport | GO:0055085 | 412 | 0.055 | |
| mitochondrial calcium ion homeostasis | GO:0051560 | 7 | 0.054 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.054 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.052 | |
| monocarboxylic acid biosynthetic process | GO:0072330 | 61 | 0.051 | |
| response to oxidative stress | GO:0006979 | 123 | 0.050 | |
| dicarboxylic acid catabolic process | GO:0043649 | 2 | 0.049 | |
| myotube differentiation | GO:0014902 | 105 | 0.048 | |
| nadp metabolic process | GO:0006739 | 6 | 0.048 | |
| response to oxygen levels | GO:0070482 | 62 | 0.047 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.046 | |
| cellular modified amino acid metabolic process | GO:0006575 | 63 | 0.045 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.044 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.044 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.043 | |
| response to nicotine | GO:0035094 | 6 | 0.043 | |
| establishment of organelle localization | GO:0051656 | 122 | 0.042 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.042 | |
| establishment or maintenance of microtubule cytoskeleton polarity | GO:0030951 | 1 | 0.042 | |
| cell cycle checkpoint | GO:0000075 | 47 | 0.041 | |
| protein oligomerization | GO:0051259 | 67 | 0.041 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.040 | |
| oocyte anterior posterior axis specification | GO:0007314 | 2 | 0.040 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.040 | |
| synaptic transmission | GO:0007268 | 329 | 0.039 | |
| aggresome assembly | GO:0070842 | 2 | 0.039 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.039 | |
| aspartate family amino acid biosynthetic process | GO:0009067 | 5 | 0.039 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.039 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.038 | |
| regulation of glycolytic process | GO:0006110 | 10 | 0.038 | |
| glutamate biosynthetic process | GO:0006537 | 2 | 0.038 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.038 | |
| actin filament polymerization | GO:0030041 | 44 | 0.036 | |
| monosaccharide biosynthetic process | GO:0046364 | 44 | 0.034 | |
| negative regulation of peptide secretion | GO:0002792 | 16 | 0.034 | |
| organic acid transport | GO:0015849 | 101 | 0.034 | |
| transition metal ion homeostasis | GO:0055076 | 54 | 0.033 | |
| regulation of glucose metabolic process | GO:0010906 | 60 | 0.033 | |
| oocyte construction | GO:0007308 | 2 | 0.033 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.032 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.032 | |
| regulation of protein localization | GO:0032880 | 231 | 0.032 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.032 | |
| spermatogenesis | GO:0007283 | 284 | 0.031 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.031 | |
| cellular divalent inorganic cation homeostasis | GO:0072503 | 127 | 0.031 | |
| pyridine nucleotide metabolic process | GO:0019362 | 12 | 0.031 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.031 | |
| mapk cascade | GO:0000165 | 281 | 0.029 | |
| regionalization | GO:0003002 | 337 | 0.029 | |
| segmentation | GO:0035282 | 93 | 0.029 | |
| circadian rhythm | GO:0007623 | 114 | 0.029 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.029 | |
| alpha amino acid metabolic process | GO:1901605 | 59 | 0.029 | |
| positive regulation of peptide secretion | GO:0002793 | 33 | 0.029 | |
| muscle system process | GO:0003012 | 141 | 0.029 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.028 | |
| amide transport | GO:0042886 | 138 | 0.028 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.028 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.028 | |
| cell maturation | GO:0048469 | 127 | 0.028 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.028 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.028 | |
| defense response to other organism | GO:0098542 | 197 | 0.027 | |
| mitochondrion organization | GO:0007005 | 134 | 0.027 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.027 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.027 | |
| regulation of secretion | GO:0051046 | 274 | 0.027 | |
| 4 hydroxyproline metabolic process | GO:0019471 | 5 | 0.027 | |
| forebrain development | GO:0030900 | 302 | 0.027 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.027 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.027 | |
| regulation of inositol 1 4 5 trisphosphate sensitive calcium release channel activity | GO:0031585 | 2 | 0.026 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.026 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.026 | |
| male gamete generation | GO:0048232 | 285 | 0.026 | |
| regulation of actin cytoskeleton organization | GO:0032956 | 84 | 0.026 | |
| t cell activation | GO:0042110 | 289 | 0.026 | |
| angiogenesis | GO:0001525 | 201 | 0.026 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.025 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.025 | |
| multicellular organismal aging | GO:0010259 | 24 | 0.025 | Worm |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.025 | |
| regulation of cofactor metabolic process | GO:0051193 | 5 | 0.025 | |
| protein ubiquitination | GO:0016567 | 171 | 0.025 | |
| glucan metabolic process | GO:0044042 | 32 | 0.025 | |
| muscle contraction | GO:0006936 | 101 | 0.025 | |
| organic anion transport | GO:0015711 | 137 | 0.025 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.025 | |
| skin development | GO:0043588 | 220 | 0.025 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.025 | |
| mitochondrial transport | GO:0006839 | 36 | 0.025 | |
| dna metabolic process | GO:0006259 | 303 | 0.025 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.025 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.025 | |
| intracellular mrna localization | GO:0008298 | 4 | 0.024 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.024 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.024 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.024 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.024 | |
| intracellular protein transport | GO:0006886 | 204 | 0.024 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.023 | |
| protein targeting to membrane | GO:0006612 | 20 | 0.023 | |
| atp catabolic process | GO:0006200 | 55 | 0.023 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.022 | |
| muscle cell cellular homeostasis | GO:0046716 | 12 | 0.022 | |
| cellular transition metal ion homeostasis | GO:0046916 | 32 | 0.022 | |
| regulation of mitochondrial membrane permeability | GO:0046902 | 17 | 0.022 | |
| adult locomotory behavior | GO:0008344 | 91 | 0.022 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.022 | |
| somite development | GO:0061053 | 81 | 0.022 | |
| cellular response to interleukin 4 | GO:0071353 | 21 | 0.022 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.022 | |
| epithelial cell development | GO:0002064 | 159 | 0.022 | |
| compound eye development | GO:0048749 | 1 | 0.022 | |
| cell aging | GO:0007569 | 35 | 0.022 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.022 | |
| tissue migration | GO:0090130 | 68 | 0.022 | |
| lateral inhibition | GO:0046331 | 1 | 0.022 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.021 | |
| tricarboxylic acid metabolic process | GO:0072350 | 5 | 0.021 | |
| respiratory tube development | GO:0030323 | 167 | 0.021 | |
| neural tube formation | GO:0001841 | 108 | 0.021 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.021 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.020 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.020 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.020 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.020 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.020 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.020 | |
| mesoderm development | GO:0007498 | 100 | 0.020 | |
| maintenance of location | GO:0051235 | 89 | 0.020 | Worm |
| response to peptide hormone | GO:0043434 | 127 | 0.020 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.020 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.020 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.020 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.020 | |
| glutamate metabolic process | GO:0006536 | 9 | 0.020 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.020 | |
| hormone secretion | GO:0046879 | 128 | 0.020 | |
| positive regulation of organelle organization | GO:0010638 | 128 | 0.020 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.020 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.019 | |
| establishment of synaptic vesicle localization | GO:0097480 | 57 | 0.019 | |
| carboxylic acid catabolic process | GO:0046395 | 51 | 0.019 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.019 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.019 | |
| protein catabolic process | GO:0030163 | 221 | 0.019 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.019 | |
| regulation of glycogen catabolic process | GO:0005981 | 2 | 0.019 | |
| reproductive behavior | GO:0019098 | 32 | 0.019 | |
| axonogenesis | GO:0007409 | 274 | 0.019 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.019 | |
| determination of adult lifespan | GO:0008340 | 11 | 0.019 | Worm |
| response to nutrient levels | GO:0031667 | 109 | 0.019 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.019 | |
| very long chain fatty acid biosynthetic process | GO:0042761 | 2 | 0.019 | |
| regulation of exit from mitosis | GO:0007096 | 1 | 0.019 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.019 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.019 | |
| regulation of cell activation | GO:0050865 | 289 | 0.019 | |
| response to peptide | GO:1901652 | 136 | 0.019 | |
| polysaccharide biosynthetic process | GO:0000271 | 20 | 0.018 | |
| cellular amino acid biosynthetic process | GO:0008652 | 22 | 0.018 | |
| cell fate commitment | GO:0045165 | 210 | 0.018 | |
| rhythmic process | GO:0048511 | 174 | 0.018 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.018 | |
| cell redox homeostasis | GO:0045454 | 6 | 0.018 | |
| cellular respiration | GO:0045333 | 38 | 0.018 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.018 | |
| cellular glucan metabolic process | GO:0006073 | 32 | 0.018 | |
| actin filament organization | GO:0007015 | 113 | 0.018 | |
| regulation of ubiquitin protein ligase activity involved in mitotic cell cycle | GO:0051439 | 1 | 0.018 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.018 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.018 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.018 | |
| regulation of cellular component size | GO:0032535 | 121 | 0.018 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.018 | |
| germ cell development | GO:0007281 | 185 | 0.018 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.018 | |
| regulation of cytoskeleton organization | GO:0051493 | 122 | 0.018 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.017 | |
| alpha amino acid catabolic process | GO:1901606 | 18 | 0.017 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.017 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.017 | |
| dna damage checkpoint | GO:0000077 | 26 | 0.017 | |
| energy reserve metabolic process | GO:0006112 | 39 | 0.017 | |
| response to light stimulus | GO:0009416 | 135 | 0.017 | |
| regulation of protein complex assembly | GO:0043254 | 83 | 0.017 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.017 | |
| response to temperature stimulus | GO:0009266 | 55 | 0.017 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.017 | |
| purine ribonucleoside monophosphate catabolic process | GO:0009169 | 57 | 0.017 | |
| organelle localization | GO:0051640 | 179 | 0.016 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.016 | |
| regulation of circadian rhythm | GO:0042752 | 58 | 0.016 | |
| cytoskeleton dependent intracellular transport | GO:0030705 | 50 | 0.016 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.016 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.016 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.016 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.016 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.016 | |
| cellular calcium ion homeostasis | GO:0006874 | 119 | 0.016 | |
| pole plasm assembly | GO:0007315 | 2 | 0.016 | |
| response to steroid hormone | GO:0048545 | 56 | 0.016 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.016 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.016 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.016 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.016 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.016 | |
| regulation of transporter activity | GO:0032409 | 57 | 0.016 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.016 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.016 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.016 | |
| maternal process involved in female pregnancy | GO:0060135 | 32 | 0.015 | |
| glycogen metabolic process | GO:0005977 | 32 | 0.015 | |
| response to inorganic substance | GO:0010035 | 96 | 0.015 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.015 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.015 | |
| wound healing | GO:0042060 | 157 | 0.015 | |
| citrulline metabolic process | GO:0000052 | 3 | 0.015 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.015 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.015 | |
| regulation of cellular ph | GO:0030641 | 12 | 0.015 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.015 | |
| multi organism behavior | GO:0051705 | 62 | 0.015 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.015 | |
| hatching | GO:0035188 | 4 | 0.015 | |
| regulation of nucleocytoplasmic transport | GO:0046822 | 73 | 0.014 | |
| ossification | GO:0001503 | 216 | 0.014 | |
| positive regulation of growth | GO:0045927 | 104 | 0.014 | Worm |
| gonad development | GO:0008406 | 141 | 0.014 | Worm |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.014 | |
| respiratory system development | GO:0060541 | 190 | 0.014 | |
| negative regulation of transposition | GO:0010529 | 2 | 0.014 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.014 | |
| cellularization | GO:0007349 | 1 | 0.014 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.014 | |
| renal system development | GO:0072001 | 225 | 0.014 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.014 | |
| hexose biosynthetic process | GO:0019319 | 39 | 0.014 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.014 | |
| amine metabolic process | GO:0009308 | 45 | 0.014 | |
| activation of cysteine type endopeptidase activity | GO:0097202 | 27 | 0.014 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.014 | |
| nuclear transport | GO:0051169 | 139 | 0.014 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.014 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.014 | |
| oogenesis | GO:0048477 | 56 | 0.014 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.014 | |
| establishment of vesicle localization | GO:0051650 | 81 | 0.014 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.014 | |
| polysaccharide metabolic process | GO:0005976 | 39 | 0.014 | |
| positive regulation of ion transport | GO:0043270 | 65 | 0.014 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.014 | Worm |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.014 | |
| maternal placenta development | GO:0001893 | 20 | 0.013 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.013 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.013 | |
| maternal determination of anterior posterior axis embryo | GO:0008358 | 2 | 0.013 | |
| heart morphogenesis | GO:0003007 | 178 | 0.013 | |
| hormone metabolic process | GO:0042445 | 86 | 0.013 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.013 | |
| plasma membrane organization | GO:0007009 | 90 | 0.013 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.013 | |
| nucleoside monophosphate catabolic process | GO:0009125 | 59 | 0.013 | |
| actin polymerization or depolymerization | GO:0008154 | 54 | 0.013 | |
| sensory perception | GO:0007600 | 245 | 0.013 | |
| mitochondrial membrane organization | GO:0007006 | 26 | 0.013 | |
| response to insulin | GO:0032868 | 100 | 0.013 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.013 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.013 | |
| dna repair | GO:0006281 | 107 | 0.013 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.013 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.013 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.013 | |
| anion transmembrane transport | GO:0098656 | 71 | 0.013 | |
| purine nucleotide transport | GO:0015865 | 2 | 0.013 | |
| odontogenesis of dentin containing tooth | GO:0042475 | 66 | 0.013 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.013 | |
| protein processing | GO:0016485 | 163 | 0.012 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.012 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.012 | |
| alditol metabolic process | GO:0019400 | 5 | 0.012 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.012 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.012 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.012 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.012 | |
| neuron death | GO:0070997 | 154 | 0.012 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.012 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.012 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.012 | |
| hydrogen transport | GO:0006818 | 35 | 0.012 | |
| single organism nuclear import | GO:1902593 | 95 | 0.012 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.012 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.012 | |
| calcium ion homeostasis | GO:0055074 | 127 | 0.012 | |
| response to interleukin 4 | GO:0070670 | 23 | 0.012 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.012 | |
| rna interference | GO:0016246 | 2 | 0.012 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.012 | |
| synaptic vesicle transport | GO:0048489 | 57 | 0.012 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.012 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.012 | |
| lung development | GO:0030324 | 164 | 0.012 | |
| cellular response to lipid | GO:0071396 | 145 | 0.012 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.012 | |
| retrograde vesicle mediated transport golgi to er | GO:0006890 | 1 | 0.012 | |
| response to radiation | GO:0009314 | 165 | 0.012 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.012 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.012 | |
| dicarboxylic acid transport | GO:0006835 | 29 | 0.012 | |
| asymmetric stem cell division | GO:0098722 | 3 | 0.012 | |
| epithelial cell migration | GO:0010631 | 63 | 0.012 | |
| primary neural tube formation | GO:0014020 | 95 | 0.012 | |
| spermatid differentiation | GO:0048515 | 115 | 0.012 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.012 | |
| positive regulation of protein complex assembly | GO:0031334 | 45 | 0.012 | |
| spermatid development | GO:0007286 | 108 | 0.012 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.011 | |
| synaptic vesicle localization | GO:0097479 | 59 | 0.011 | |
| regulation of actin filament length | GO:0030832 | 45 | 0.011 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.011 | |
| glutamine family amino acid metabolic process | GO:0009064 | 15 | 0.011 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.011 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.011 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.011 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.011 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.011 | |
| response to estrogen | GO:0043627 | 24 | 0.011 | |
| membrane organization | GO:0061024 | 245 | 0.011 | |
| gluconeogenesis | GO:0006094 | 39 | 0.011 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.011 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.011 | |
| cytokine production | GO:0001816 | 319 | 0.011 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.011 | |
| learning or memory | GO:0007611 | 148 | 0.011 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.011 | |
| regulation of actin polymerization or depolymerization | GO:0008064 | 45 | 0.011 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.011 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.011 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.011 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.011 | |
